Clindamycin Spectrum of Activity and Clinical Implications

Spectrum of Activity

Clindamycin has clinically useful activity against anaerobic bacteria, including Bacteroides fragilis and other gram-negative anaerobes, as well as aerobic gram-positive cocci, such as Staphylococcus aureus, streptococci, and group B streptococci, according to the Infectious Diseases Society of America 1, 2
Clindamycin also covers gram-positive anaerobic cocci, such as Peptostreptococcus species 1

The American College of Clinical Pharmacology recommends that clindamycin should never be used as monotherapy when gram-negative pathogens are suspected, due to its lack of activity against aerobic gram-negative bacteria 1, 2
Clindamycin must be combined with agents that cover aerobic gram-negative bacteria, such as aminoglycosides or fluoroquinolones, when treating mixed infections, as recommended by the Infectious Diseases Society of America 1, 2
For polymicrobial infections, such as necrotizing fasciitis or intra-abdominal infections, the recommended combinations include clindamycin plus an aminoglycoside, such as gentamicin or tobramycin, or clindamycin plus a fluoroquinolone, such as ciprofloxacin, according to the Surgical Infection Society 1, 2
The Infectious Diseases Society of America recommends against using clindamycin alone for intra-abdominal infections where E. coli and other gram-negative aerobes are expected pathogens 3
In bite wound infections, clindamycin misses important gram-negative pathogens, such as Pasteurella multocida and Eikenella corrodens, requiring alternative or combination therapy, as recommended by the Infectious Diseases Society of America 4, 5

The Infectious Diseases Society of America recommends penicillin plus clindamycin for streptococcal necrotizing infections, where the beta-lactam provides bactericidal activity and clindamycin adds toxin suppression 6
Amoxicillin-clavulanic acid combined with clindamycin plus gentamicin represents an acceptable prophylactic regimen for certain head and neck procedures 7
The combination of high-dose amoxicillin or clindamycin plus cefixime is considered reasonable for polymicrobial diabetic foot infections 8
High-dose amoxicillin or clindamycin plus cefixime, or high-dose amoxicillin or clindamycin plus rifampin, may be used for children with moderate disease who fail initial therapy 8

Single-agent amoxicillin-clavulanate provides both aerobic and anaerobic coverage without needing clindamycin for most community-acquired infections 6, 9
Guidelines recommend single agents like ertapenem, piperacillin-tazobactam, or combinations like ceftriaxone plus metronidazole rather than amoxicillin plus clindamycin for intra-abdominal infections 9
Amoxicillin-clavulanate alone is the preferred oral treatment for animal or human bites, eliminating the need for clindamycin 6

Consider single-agent alternatives first, such as amoxicillin-clavulanate, ertapenem, or piperacillin-tazobactam, which often provide adequate coverage without requiring combination therapy 9, 7
When combining these agents, use high-dose amoxicillin (90 mg/kg/day in children, 3g in adults) to ensure adequate gram-negative coverage 8